Takeda Ruling Could Limit FCA Enforcement, 1st Circ. Hears
The federal government on Thursday asked the First Circuit to overturn a ruling that Takeda Pharmaceutical Co. Ltd. wasn't liable for failure to tell the U.S. Food and Drug Administration about...To view the full article, register now.
Already a subscriber? Click here to view full article